Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Seiler

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
European Urology Oncology|March 25, 2020
Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific DifferencesJoep J de Jong, Joost L Boormans, Bas W G van Rhijn, et al.
Urology Case Reports|October 8, 2016
Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case ReportHyun Kim, Mohammed Alshalalfa, Jean Hoffman-Censits, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Ewan A Gibb, Natalie Q Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 2, 2026
Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screeningCarlotta Frascolla, Riccardo Mastroianni, Catarina Macedo-Silva, et al.
European Urology|September 30, 2019
A Consensus Molecular Classification of Muscle-invasive Bladder CancerAurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
JAMA Oncology|May 12, 2017
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation TherapyShuang G Zhao, S Laura Chang, Nicholas Erho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Molecular Characterization of Neuroendocrine-like Bladder CancerJosé Batista da Costa, Ewan A Gibb, Trinity J Bivalacqua, et al.
European Urology|April 15, 2017
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder CancerRoland Seiler, Htoo Zarni Oo, Davide Tortora, et al.
Nature Communications|July 26, 2017
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature Communications|June 6, 2019
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
European Urology Oncology|March 25, 2020
Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific DifferencesJoep J de Jong, Joost L Boormans, Bas W G van Rhijn, et al.
Urology Case Reports|October 8, 2016
Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case ReportHyun Kim, Mohammed Alshalalfa, Jean Hoffman-Censits, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Ewan A Gibb, Natalie Q Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 2, 2026
Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screeningCarlotta Frascolla, Riccardo Mastroianni, Catarina Macedo-Silva, et al.
European Urology|September 30, 2019
A Consensus Molecular Classification of Muscle-invasive Bladder CancerAurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
JAMA Oncology|May 12, 2017
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation TherapyShuang G Zhao, S Laura Chang, Nicholas Erho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Molecular Characterization of Neuroendocrine-like Bladder CancerJosé Batista da Costa, Ewan A Gibb, Trinity J Bivalacqua, et al.
European Urology|April 15, 2017
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder CancerRoland Seiler, Htoo Zarni Oo, Davide Tortora, et al.
Nature Communications|July 26, 2017
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature Communications|June 6, 2019
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Pageof 14